Next |
home / stock / canf / canf message board
Subject | By | Source | When |
---|---|---|---|
Can-Fite to Present at the Emerging Growth Conference | midastouch017 | investorshub | 07/07/2023 12:12:19 PM |
$CANF Price now last up | kindness | investorshub | 07/05/2023 12:30:23 PM |
$CANF MomentumIts gaining last up | midastouch017 | investorshub | 07/02/2023 3:49:17 AM |
$CANF Price gaining | JoEy D BuLL | investorshub | 07/01/2023 12:07:54 AM |
$CANF Price gaining last trade up | midastouch017 | investorshub | 06/29/2023 2:57:59 PM |
Can-Fite Receives U.S. FDAs Go Ahead for Piclidenoson | midastouch017 | investorshub | 06/29/2023 11:43:15 AM |
are we finally gonna see some action | midastouch017 | investorshub | 06/27/2023 5:02:56 AM |
$CANF are we finally gonna see some action | kindness | investorshub | 06/26/2023 3:30:58 PM |
MomentumIts gaining last trade up | kindness | investorshub | 06/25/2023 1:21:58 PM |
Time for a bounce? | midastouch017 | investorshub | 06/21/2023 3:51:44 PM |
$CANF Have a look at this | The Stock Reader | investorshub | 06/21/2023 1:29:33 PM |
great news | Zadie420 | investorshub | 06/21/2023 7:56:34 AM |
The gaining | midastouch017 | investorshub | 06/20/2023 8:34:08 PM |
Can-Fite up 6% premarket on planned IND for | midastouch017 | investorshub | 06/13/2023 12:18:18 PM |
Can-Fite to Submit IND for the Treatment of | midastouch017 | investorshub | 06/13/2023 12:10:59 PM |
$CANF Price gaining | midastouch017 | investorshub | 06/10/2023 10:31:17 AM |
Seems nobody is interested in partnering with $CANF. | midastouch017 | investorshub | 06/08/2023 1:02:12 PM |
$CANF short data if anyone is interested | midastouch017 | investorshub | 06/07/2023 12:01:39 AM |
Can-Fite to Participate in Out-licensing and Distribution Partnering | midastouch017 | investorshub | 06/02/2023 12:17:19 PM |
Can-Fite Reports First Quarter 2023 Financial Results & | midastouch017 | investorshub | 06/01/2023 12:25:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Can-Fite Biopharma Ltd Sponsored ADR Company Name:
CANF Stock Symbol:
NYSE Market:
A pivotal Phase III trial for advanced liver cancer, approved by FDA & EMA and a MASH Phase IIb are enrolling patients Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address onc...
Namodenoson demonstrated anti-fibrosis, anti-steatosis and anti-inflammatory effects in former Phase IIa study Patient enrolment for Phase IIb study is ongoing in Europe and Israel Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipelin...
Ramat Gan, Israel--(Newsfile Corp. - April 1, 2024) - Can-Fite BioPharma, Ltd. (NYSE American: CANF) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the Sofitel New York on April 8th-9th, 2024. The event is expected to feature 80 companies presenting in ha...